New Drug Application resubmitted to FDA for Furoscix (subcutaneous furosemide) for treatment of congestion in patients with heart failure

Furoscix is a proprietary furosemide solution formulated to a neutral pH to allow for subcutaneous infusion via a wearable, pre-programmed on-body drug delivery system for outpatient self-administration for worsening heart failure due to congestion.

Biospace Inc.